CLLSCellectis S.A.
3.405USDMkt Cap: 342.89M $P/E: —3d ago
Cellectis S.A., a clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and g…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap342.89M $
Enterprise Value161.20M $
Revenue (TTM)63.82M $
Gross Profit63.15M $
Net Income (TTM)-67.59M $
Revenue/Share0.6350 USD
Last Price3.405 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees224
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINFR0010425595
Valuation
P/E (Trailing)—
P/E (Forward)-5.49
PEG—
EV/EBITDA-3.45
EV/Revenue2.53
P/S5.37
P/B6.03
EPS (TTM)-0.64
EPS (Forward)-0.62
52W Range
3.20173% of range3.480
52W High3.480 USD
52W Low3.201 USD
Profitability
Gross Margin86.57%
Oper. Margin-340.69%
EBITDA Margin-73.13%
Profit Margin-92.66%
ROE-89.05%
ROA-20.82%
Growth
Revenue Growth-62.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-39.40M $
CapEx (TTM)3.53M $
FCF Margin168.75%
FCF Yield31.41%
Net Debt-86.34M $
Net Debt/EBITDA1.85
Balance Sheet
Debt/Equity1.20
Current Ratio1.37
Quick Ratio1.34
Book Value/Sh0.5650 USD
Cash/Share2.293 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)7.600 USD
Upside (mean)+123.2%
Target Range4.000 USD – 10.00 USD
$4.000+123.2% to mean$10.00
# Analysts5
Ownership
Shares Out.72.70M
Float46.79M
Insiders0.00%
Institutions15.36%
Short Interest
Short Ratio19.3d
Short % Float0.54%
Short % Out.0.29%
Shares Short295.91K
Short (prev mo.)321.88K
Technical
SMA 502.944 (+15.7%)
SMA 2003.699 (-7.9%)
Beta2.75
S&P 52W Chg19.18%
Avg Vol (30d)26.95K
Avg Vol (10d)20.34K
Technical Indicators
RSI (14)65.1
MACD0.1027
MACD Signal0.0316
MACD Hist.+0.0711
BB Upper3.391 USD
BB Middle2.952 USD
BB Lower2.513 USD
BB Width29.73%
ATR (14)0.1869 USD
Vol Ratio (20d)1.47x